Most companies don't survive for decades, much less pay regular dividends for that long. Healthcare leaders Merck (NYSE: MRK) ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Sinocare announced recently that it successfully defended itself in court against trademark infringement claims brought by ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

The global glucose monitoring devices market was valued at USD 14.1 billion in 2023 and is expected to grow to USD 15.67 ...

The FreeStyle Libre 3 system helped Nathan manage his diabetes. Now, he's sharing his story to help lift stigma.Abbott NORTHAMPTON, MA / ACCESS Newswire / February 7, 2025 / As a competitive powerlift ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As ...

The upsized offering has put Beta Bionics at the higher end of healthcare IPOs in the past year, the sharp end especially for medical device companies ... the plunge into an insulin pump and ...

The introduction of the continuous glucose monitor made that unnecessary. The small device, typically attached to the arm, has a sensor under the skin that sends readings to an app on a phone or ...

The introduction of the continuous glucose monitor (CGM) made that unnecessary. The small device, typically attached to the arm, has a sensor under the skin that sends readings to an app on a phone or ...